Evidence map›Paper›PMID 33817753›Full record

ArticleAnalytical and bioanalytical chemistry2021

Analysis of 14 endocannabinoids and endocannabinoid congeners in human plasma using column switching high-performance atmospheric pressure chemical ionization liquid chromatography-mass spectrometry.

Cristina Sempio, Jelena Klawitter, Matthew Jackson, Francesca Freni, Ryan Shillingburg, Kent Hutchison, L Cinnamon Bidwell, Uwe Christians, Jost Klawitter

Abstract read
In one paragraph

Article in Analytical and bioanalytical chemistry, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
2.3field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it, 20 citations in OpenAlex.

  1. Pooled it
  2. Glucocorticoid-endocannabinoid crosstalk in the ventrolateral periaqueductal gray (vlPAG) promotes pain resolution.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2026
    Article
  3. Review
  4. Article
  5. Article
  6. Observational
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Molecular pharmacology · 2024
    Article
  13. Article
  14. Quantification of Endocannabinoids in Human Plasma.Methods in molecular biology (Clifton, N.J.) · 2023
    Article
  15. Article
  16. Endocannabinoid System in Polycystic Kidney Disease.American journal of nephrology · 2022
    Article
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Cristina SempioDepartment of Anesthesiology, University of Colorado Anschutz Medical Campus, Aurora, CO, 80045, USA.
Jelena KlawitterDepartment of Anesthesiology, University of Colorado Anschutz Medical Campus, Aurora, CO, 80045, USA.
Matthew JacksonDepartment of Anesthesiology, University of Colorado Anschutz Medical Campus, Aurora, CO, 80045, USA.
Francesca FreniDepartment of Anesthesiology, University of Colorado Anschutz Medical Campus, Aurora, CO, 80045, USA.
Ryan ShillingburgDepartment of Anesthesiology, University of Colorado Anschutz Medical Campus, Aurora, CO, 80045, USA.
Kent HutchisonInstitute of Cognitive Science, University of Colorado Boulder, Boulder, CO, 80309, USA.
L Cinnamon BidwellInstitute of Cognitive Science, University of Colorado Boulder, Boulder, CO, 80309, USA.
Uwe ChristiansDepartment of Anesthesiology, University of Colorado Anschutz Medical Campus, Aurora, CO, 80045, USA.
Jost KlawitterDepartment of Anesthesiology, University of Colorado Anschutz Medical Campus, Aurora, CO, 80045, USA. jost.klawitter@cuanschutz.edu.
University of Colorado Anschutz Medical Campus · USUniversity of Colorado Boulder · USUniversity of Pavia · IT

Funding

Rocky Mountain Cannabis Research CenterP50DA056408 · NIDA · UNIVERSITY OF COLORADO DENVER · PI KENT E. HUTCHISON · 2023 to 2026
$14.0M
Marijuana Harm Reduction: Innovative Strategies for Developing New KnowledgeR01DA039707 · NIDA · UNIVERSITY OF COLORADO DENVER · PI HUTCHISON, KENT E. · 2016 to 2020
$2.2M
Colorado Department of Public Health and Environment 96947NIDA NIH HHS DA039707NIDA NIH HHS P50 DA056408NIDA NIH HHS R01 DA039707
6 · The paper itself

Abstract

The endocannabinoid system (ECS) is a complex cell-signaling system. To address the growing need of analytics capturing endocannabinoid levels to investigate the ECS, we developed and validated an assay for the quantitative analysis of 14 endocannabinoids and congeners. A simple extraction using protein precipitation with acetonitrile followed by online-trapping high-performance liquid chromatography-tandem mass spectrometry (LC/LC-MS/MS) was used to monitor the levels of 14 endocannabinoids in plasma. The assay was validated and intra-run and inter-run accuracies and imprecisions as well as matrix effects, recoveries, and sample stabilities were determined. As a proof of concept, a subset of study samples after naturalistic administration of Cannabis flower and concentrate was analyzed. With the exception of N-oleoyl dopamine and oleamide, all endocannabinoids fulfilled the predefined acceptance criteria. Reproducible recoveries and no significant matrix effects were observed. Sample stability was an issue. Analysis of the proof-of-concept study samples revealed a significantly (p = 0.006) higher concentration of docosatetraenoyl ethanolamide in concentrate users (300 ± 13 pg/mL) compared to flower users (252 ± 11 pg/mL). A robust, sensitive high-throughput assay for the quantitation of 14 endocannabinoids and congeners was successfully validated. Our study showed that it is mandatory to (A) appropriately stabilize samples and (B) separate and separately quantify 1-AG and 2-AG; otherwise, study results are unreliable. The analysis of study samples from Cannabis flower users versus Cannabis concentrate users revealed higher levels of docosatetraenoyl ethanolamide and anandamide (n.s.) in high THC concentrate users in accordance with the existing literature, supporting the validity of the assay measurements. Graphical abstract.

Indexed as

CannabisAtmospheric PressureChromatography, High Pressure LiquidEndocannabinoidsHumansLimit of DetectionMass SpectrometryProof of Concept StudyQuality ControlReproducibility of ResultsEndocannabinoids2-ArachidonoylglycerolAnandamideCannabinoidsDocosatetraenoyl ethanolamideEndocannabinoidsEndocannabinoid System

Identifiers

PMID33817753
PMCPMC13250796
OpenAlexW3144588857

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.